Skip to main content

Table 1 Patient characteristics at baseline

From: Quality of life and fatigue of patients with spinal bone metastases under combined treatment with resistance training and radiation therapy- a randomized pilot trial

  

Intervention group (n = 30)

Control group (n = 30)

  

n

%

n

%

Age (years)

     
 

Mean (SD)

61.3 (10.1)

 

64.1 (10.9)

 

Gender

     
 

Male

14

46.7

19

63.3

 

Female

16

53.3

11

36.7

Body Mass Index

    
 

Mean (SD)

25.3 (4.5)

 

24.4 (3.6)

 

Karnofsky PS (median, range)

80 (70-100)

 

80 (70-100)

 

Primary site

     
 

Lung

12

9.2

8

26.6

 

Breast

5

16.7

6

20.1

 

Prostate

5

16.7

9

30.1

 

Melanoma

1

3.3

1

3.3

 

Kidney

1

3.3

2

6.7

 

Other

6

20.1

4

13.4

Spinal metastases site

    
 

Thoracic

17

56.7

14

46.7

 

Lumbar

9

30.0

13

43.3

 

Thoracic and lumbar

2

6.7

2

6.7

 

Sacrum

2

6.7

1

3.3

Number of metastases

    
 

Mean (range)

1.4 (2-4)

 

1.7 (1-5)

 
 

Solitary

22

73.3

18

60.0

 

Multiple

8

26.7

12

40.0

Type of metastases

    
 

Mixed

2

6.7

2

6.7

 

Osteoblast

9

30.0

10

33.3

 

Osteolytic

19

63.3

18

60.0

Concomitant metastases at baseline

   
 

Visceral

12

40.0

5

16.7

 

Brain

3

10.0

3

10.0

 

Lung

7

23.3

4

13.3

 

Tissue

8

26.7

6

20.0

Hormonotherapy

10

33.3

16

53.3

Immunotherapy

7

23.3

5

16.7

Chemotherapy

25

83.3

20

66.7

Pathological fracture at baseline

6

20.0

9

30.0

Neurological deficit

0

0.0

2

6.7

  1. SD Standard deviation.